Startups · 58m ago
OpenAI Researcher Miles Wang in Talks to Launch $2B AI Drug Discovery Startup
Miles Wang, an OpenAI researcher, is reportedly in discussions to launch an AI drug discovery startup valued at $2 billion. Lightspeed is in talks to lead the funding round, according to sources. The venture aims to apply AI to accelerate pharmaceutical development.
Meridian48 take
The $2B valuation before any product launch underscores the AI gold rush in biotech, but drug discovery remains notoriously hard to de-risk.
Read the full reporting
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B →
TechCrunch AI
ai-drug-discoverystartup-funding